$HLYK Balance Sheet | Understand Stock

$HLYK

$2.60 -$0.05 (1.81%) Close

$HLYK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current Assets
Earned sale consideration receivable
Accounts receivable, net of allowance for doubtful accounts of $-0- and $-0- as of December 31, 2024 and 2023, respectively
Cash
Inventory, net
Contract assets
Prepaid expenses and other current assets
Contingent sale consideration receivable, current portion
Contingent sale consideration receivable
Current assets held for sale
Total Current Assets
Property and equipment, net of accumulated depreciation of $764,979 and $728,710 as of June 30, 2026 and December 31, 2025, respectively
Intangible assets, net of accumulated amortization of $873,417 and $151,776 as of December 31, 2021 and 2020, respectively
Intangible assets, net of accumulated amortization of $1,052,338 and $873,417 as of March 31, 2022 and December 31, 2021, respectively
Intangible assets, net of accumulated amortization of $-0- and $258,690 as of December 31, 2024 and 2023, respectively
Goodwill
Right of use lease assets
Long term assets held for sale
Deposits, long term portion
Total Assets

Current Liabilities
Accounts payable, accrued expenses and other current liabilities
Contract liabilities
Lease liability, current portion
Due to related party, current portion
Notes payable and other amounts due to related party, net of unamortized original issue discount of $104,490 and $-0- as of December 31, 2022 and 2021, respectively
Notes payable and other amounts due to related party, net of unamortized original issue discount of $79,860 and $104,490 as of June 30, 2023 and December 31, 2022, respectively
Notes payable and other amounts due to related party, net of unamortized original issue discount of $281,579 and $34,834 as of March 31, 2024 and December 31, 2023, respectively
Related Party
Total notes payable and other amounts due to related party, net of unamortized original issue discount of $281,579 and $34,834 as of March 31, 2024 and December 31, 2023, respectively

Derivative financial instruments
Notes payable and other amounts due to related party, net of unamortized discounts of $5,261 and $-0- as of June 30, 2026 and December 31, 2025, respectively
Related Party
Total notes payable and other amounts due to related party, net of unamortized discounts of $5,261 and $-0- as of June 30, 2026 and December 31, 2025, respectively

Notes payable, current portion, net of unamortized discounts of $134,091 and $109,027 as of June 30, 2026 and December 31, 2025, respectively
Liability-classified equity instruments, current portion
Indemnification liability
Contingent acquisition consideration, current portion
Other current liabilities
Current liabilities held for sale
Total Current Liabilities

Long-Term Liabilities
Government and vendor notes payable, long term portion
Lease liability, long term portion
Government notes payable, long term portion
Liability-classified equity instruments, long term portion
Contingent acquisition consideration, long term portion
Other long-term liabilities
Government and other notes payable, long term portion
Total Liabilities

Shareholders’ Deficit
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 2,953,225 and 2,881,104 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and 2,750,000 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Common stock issuable, $0.0001 par value; 132,597 and 22,052 as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total Shareholders’ Deficit
Total Liabilities and Shareholders’ Deficit

Comments